News & Press
John Aitchison, President and Director
In a unanimous vote, the Board of Trustees of the Center for Infectious Disease Research appointed Dr. John Aitchison as the third president and director in our 40 year history.Aitchison steps into h...
JCI Insight highlights paper examining relationship between BCG TB vaccine and levels of activated HIV target cells
Journal of Clinical Investiagtion
Chronic HIV-1 infection impairs superantigen-induced activation of peripheral CD4+CXCR5+PD-1+ cells, with relative preservation of recall antigen-specific responses
Journal of Acquired Immune Deficiency Syndromes
Repertoire comparison of the B-cell receptor-encoding loci in humans and rhesus macaques by next-generation sequencing
Clinical & Translational Immunology
Seattle is hub of innovation in combating infectious diseases like Ebola
The Seattle Times
No results were foundLoad more (70)
Help us save 15 million lives
A vaccine for HIV/AIDS or TB will save 15 million lives in the coming decade and we've never been closer.